BioSpace News Archive

Drug Development

Kamada Ltd. Reports New Data From an Extension Study of Its Phase I/II Trial With Glassia in Pediatric Patients With Type 1 Diabetes

October 31, 2013
·
1 min read
Business

Cerus Corporation and the Swiss Red Cross Renew Commercial Contract With a Five-Year National Purchase Agreement for the INTERCEPT Blood System for Platelets

October 31, 2013
·
1 min read
Drug Development

Clovis Oncology Announces First Patient Enrolled in ARIEL2 Study of Rucaparib in Ovarian Cancer

October 31, 2013
·
1 min read
Drug Development

Protalex, Inc. Initiates Enrollment of Final Cohort in Phase 1b Trial of PRTX-100 in Active Rheumatoid Arthritis Patients

October 31, 2013
·
1 min read
Pharm Country

Lutonix, Inc. Six-Month Results Presented on First IDE Trial for Drug-Coated Balloons

October 31, 2013
·
1 min read
Drug Development

Esperion Therapeutics, Inc. Announces Initiation of Phase 2b Clinical Study of ETC-1002 in Patients With or Without Statin Intolerance and Hypercholesterolemia

October 31, 2013
·
1 min read
Drug Development

CytoDyn Submits Phase IIb Protocol for PRO 140 Clinical Trial to FDA

October 31, 2013
·
1 min read
Business

Fidelity Biosciences and REGENX Biosciences, LLC Form New Company Dimension Therapeutics

October 31, 2013
·
4 min read
Genetown

Synta Pharmaceuticals Announces Publication of First Patent Application Covering Its Hsp90-inhibitor Drug Conjugate (HDC) Platform

October 31, 2013
·
1 min read
Business

Greer Labs and Stallergenes, S.A. Sign Exclusive Agreement for United States Commercialization Rights to Oralair®

October 31, 2013
·
1 min read